top of page
Slide Backgroud - Test tube 3.png

Blurring the line between in vitro and in vivo testing.

3D Health Solution's canine organoid technology models the in vivo effects of therapeutics or nutraceuticals, but early in the development process. 

Organoid.png

3D Health Solutions organoids are induced from adult stem cells resulting in: 

  • Specialized Cells

  • Organ Structure and Function

  • Healthy or Disease Models

Slide Backgroud - syringe_edited.jpg

Efficiently advancing or eliminating drug or nutritional targets early in the development process enables simultaneously reducing R&D cost and increasing R&D capacity.

Organoid technology dramatically improves translation compared to standard in vitro assays, allowing for early selection and focus on the most promising drug and nutrition candidates. As a result, organoids reduce or even eliminate live animal studies and their associated costs, while accelerating the development process.

Drug Discovery and Development logo.png

3D Health Solution's partnership with the U.S. FDA Center for Veterinary Medicine meets objectives that are outlined in the Modernization Act 2.0, which has ambitions to eliminate the requirement for live animal testing. 

Senate passes drug modernization act.png

CUSTOM RESEARCH

3DHS provides CRO services, working with our customers on research design, performing studies and reporting results 

MODEL CO-DEVELOPMENT

3DHS works in partnerships to develop proprietary models for specific applications, which can then be licensed.  

PRODUCTS

3DHS is working towards the ability to provide organoid tissues and media directly to customers or via distributors.  

Partners

Our technology is being developed in partnership with the U.S. FDA Center for Veterinary Medicine, the National Science foundation and the National Cancer Institute.  

Customers

We serve leading enterprise and institutions like the ones shown below. 

Contact Us

We would be happy to answer any questions you have or schedule a web conference to present our data.  

Thanks for submitting!

Subscribe

If you would like to join our mailing list please enter your email below.  We won't overwhelm you.  

Please enter your email to join to our mailing list.  

Thanks for submitting!

bottom of page